Type | Name | Gene Symbol | Clinical Significance | Chromosome | Start | Stop | Reference Allele | Alternate Allele | Review Status | Other IDs |
---|---|---|---|---|---|---|---|---|---|---|
(GRCh37) | ||||||||||
single nucleotide variant | NM_000059.4(BRCA2):c.517G>C (p.Gly173Arg) | BRCA2 | Pathogenic/Likely pathogenic | 13 | 32900636 | 32900636 | G | C | criteria provided, multiple submitters, no conflicts | ClinGen:CA021599 |
Duplication | NM_000059.4(BRCA2):c.670_673dup (p.Thr225fs) | BRCA2 | Pathogenic | 13 | 32903617 | 32903618 | T | TGATA | reviewed by expert panel | ClinGen:CA024350 |
Duplication | NM_000059.4(BRCA2):c.2380dup (p.Met794fs) | BRCA2 | Pathogenic | 13 | 32910868 | 32910869 | C | CA | reviewed by expert panel | ClinGen:CA015082 |
Deletion | NM_000059.4(BRCA2):c.3010del (p.Ser1004fs) | BRCA2 | Pathogenic | 13 | 32911502 | 32911502 | CA | C | reviewed by expert panel | ClinGen:CA017044 |
single nucleotide variant | NM_000059.4(BRCA2):c.3172A>T (p.Lys1058Ter) | BRCA2 | Pathogenic | 13 | 32911664 | 32911664 | A | T | reviewed by expert panel | ClinGen:CA017460 |
Deletion | NM_000059.4(BRCA2):c.3820_3823del (p.Phe1273_Lys1274insTer) | BRCA2 | Pathogenic | 13 | 32912312 | 32912315 | TAAGA | T | reviewed by expert panel | ClinGen:CA018870 |
Duplication | NM_000059.4(BRCA2):c.4112dup (p.Phe1372fs) | BRCA2 | Pathogenic | 13 | 32912603 | 32912604 | C | CA | reviewed by expert panel | ClinGen:CA019549 |
Deletion | NM_000059.4(BRCA2):c.4168_4169del (p.Leu1390fs) | BRCA2 | Pathogenic | 13 | 32912656 | 32912657 | CTT | C | reviewed by expert panel | ClinGen:CA019652 |
Deletion | NM_000059.4(BRCA2):c.4277del (p.Thr1426fs) | BRCA2 | Pathogenic | 13 | 32912769 | 32912769 | AC | A | reviewed by expert panel | ClinGen:CA019898 |
Duplication | NM_000059.4(BRCA2):c.6267_6270dup (p.Ser2091delinsAlaTer) | BRCA2 | Pathogenic | 13 | 32914758 | 32914759 | A | AGCAT | reviewed by expert panel | ClinGen:CA023803 |